Michela Ansuinelli | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
DROPLET DIGITAL PCR DETECTION OF THE T315I BCR::ABL1 KD MUTATION IN ADULT PH-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA	European Hematology Association (EHA) 2023 Open Library	2023
Digital droplet PCR for T315I BCR::ABL1 KD mutation assessment in adult Ph-positive acute lymphoblastic leukemia with a minimal residual disease increase	LEUKEMIA & LYMPHOMA	2023
Cytokine release syndrome in haploidentical stem cell transplant may impact T-cell recovery and relapse	BLOOD ADVANCES	2023
Blast morphology in the diagnostic work-up of Ph-like acute lymphoblastic leukemia	LEUKEMIA & LYMPHOMA	2022
Circulating cell‐free DNA for target quantification in hematologic malignancies: Validation of a protocol to overcome pre‐analytical biases	HEMATOLOGICAL ONCOLOGY	2022
ZNF384 rearrangement is the most frequent genetic lesion in adult PH-negative and Ph-like-negative B-other acute lymphoblastic leukemia. Biological and clinical findings	LEUKEMIA & LYMPHOMA	2022
A multicenter total therapy strategy for de novo adult Philadelphia chromosome positive acute lymphoblastic leukemia patients. Final results of the GIMEMA LAL1509 protocol	HAEMATOLOGICA	2021
New dead/H-Box helicase gene (Ddx41) mutation in an italian family with recurrent leukemia.	LEUKEMIA & LYMPHOMA	2021
Emerging tyrosine kinase inhibitors for the treatment of adult acute lymphoblastic leukemia	EXPERT OPINION ON EMERGING DRUGS	2021
Applicability of droplet digital polymerase chain reaction for minimal residual disease monitoring in Philadelphia-positive acute lymphoblastic leukaemia	HEMATOLOGICAL ONCOLOGY	2021
Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimale residual disease-oriented GIMEMA LAL1913	HAEMATOLOGICA	2020
Relapsed/refractory diffuse large B-cell lymphoma patients. A multicenter retrospective analysis of eligibility criteria for car-T cell therapy	LEUKEMIA & LYMPHOMA	2020
Oral mucositis prevention in allogeneic hematopoietic stem cell transplantation with the photobyomodulation: A single center case series	BONE MARROW TRANSPLANTATION	2019
Incidence and outcome of severe complications in patients with paroxysmal nocturnal hemoglobinuria: A real life scenario from a single center 30 years experience	BONE MARROW TRANSPLANTATION	2019
A 35 year single center transplant experience in chronic myeloid leukemia	BONE MARROW TRANSPLANTATION	2019
Concomitant Treatment with Ruxolitinib and Deferasirox in the Management of Iron Overload in Patients with Myelofibrosis: A Multicenter Italian Experience	BLOOD	2019
Immune-hematologic monitoring after allogeneic stem cell transplantation: unicentric prospective study on 104 patients.	BONE MARROW TRANSPLANTATION	2018
Multiparametric Magnetic Resonance Enterography for the Diagnosis and Staging of Intestinal Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation	BONE MARROW TRANSPLANTATION	2018
. BEAM vs FEAM conditioning: retrospective study in lymphoma patients undergoing autologous stem cell transplant.	BONE MARROW TRANSPLANTATION	2018
Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice (the Lenamant Study)	THE ONCOLOGIST	2018